임상의사결정지원시스템 시장 : 예측(2024-2029년)

The clinical decision support systems market is expected to grow at a CAGR of 10.13%, reaching a market size of US$5.043 billion in 2029 from US$3.113 billion in 2024.

In light of the continuous digital transformation in the healthcare sector, encompassing telehealth and the utilization of electronic health records (EHRs), there is a high demand for clinical decision support (CDS) systems. These systems play a quintessential position in improving affected person care and techniques by employing digital information to provide medical doctors with actual-time information and guidelines on strategies.

Healthcare organisations utilise CDS systems to reduce clinical errors and adverse events as patient safety becomes increasingly important. These systems provide evidence-based popular guidelines, indicators for potential risks, and scientific hints, permitting healthcare experts to make well-knowledgeable selections that improve patient safety and reduce the harm related to healthcare.

Moreover, a vast opportunity is furnished by way of the incorporation of CDS functionalities into telemedicine structures. By providing doctors with various health kits, diagnostic equipment, and treatment guidelines, this integration improves far-off painting patient consultations and increases the already high efficacy of telemedicine offerings.

Clinical decision support systems market drivers?

• Technological advancement and increased adoption of EHRs is anticipated to boost the market growth

The development of electronic health records has been substantially aided by the fast developments in healthcare IT. Clinical information analytics, artificial intelligence, and device learning have advanced CDS, making them more powerful and user-pleasant. The integration of these systems with EHRs is a huge improvement that allows medical workflow control and easy records.

Moreover, the big use of electronic health records lays a strong base for the seamless integration of CDS systems into scientific tactics. This enhances the pride and performance of scientific selections by obviating the need for patient data while allowing necessary resources in the actual context of the individual.

Clinical decision support systems market - geographical outlooks

• North America is witnessing exponential growth during the forecast period

Adopting digital health information (EHRs), interoperable healthcare systems and a strong company network are all part of the United States' advanced healthcare infrastructure. This enables non-stop integration and use of CDS programs throughout various healthcare environments, enhancing clinical strategies and selection-making guidelines.

In addition, the healthcare device in the US is constructed toward incorporating digital health file structures, end-to-quit well-matched healthcare facilities, and a ready network of healthcare companies. This guarantees that any CDS software systems implemented in these health facilities are maintained long-term and maximally leveraged across enhancement of the clinical offerings. Hence, it is bringing about an exceptional class of medical intervention and decision-making processes.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2029
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Clinical decision support systems market is segmented and analyzed as follows:

By Delivery Mode

• Cloud-based Systems
• Web-based Systems
• On-Premise Systems

By Component

• Hardware
• Software
• Service

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. CLINICAL DECISION SUPPORT SYSTEMS MARKET BY DELIVERY MODE

• 5.1. Introduction
• 5.2. Cloud-based Systems
• 5.3. Web-based Systems
• 5.4. On-Premise Systems

6. CLINICAL DECISION SUPPORT SYSTEMS MARKET BY COMPONENT

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Software
• 6.4. Service

7. CLINICAL DECISION SUPPORT SYSTEMS MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. By Delivery Mode
  • 7.2.2. By Component
  • 7.2.3. By Country
    • 7.2.3.1. United States
    • 7.2.3.2. Canada
    • 7.2.3.3. Mexico
• 7.3. South America
  • 7.3.1. By Delivery Mode
  • 7.3.2. By Component
  • 7.3.3. By Country
    • 7.3.3.1. Brazil
    • 7.3.3.2. Argentina
    • 7.3.3.3. Others
• 7.4. Europe
  • 7.4.1. By Delivery Mode
  • 7.4.2. By Component
  • 7.4.3. By Country
    • 7.4.3.1. United Kingdom
    • 7.4.3.2. Germany
    • 7.4.3.3. France
    • 7.4.3.4. Italy
    • 7.4.3.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. By Delivery Mode
  • 7.5.2. By Component
  • 7.5.3. By Country
    • 7.5.3.1. Saudi Arabia
    • 7.5.3.2. Israel
    • 7.5.3.3. Others
• 7.6. Asia Pacific
  • 7.6.1. By Delivery Mode
  • 7.6.2. By Component
  • 7.6.3. By Country
    • 7.6.3.1. Japan
    • 7.6.3.2. China
    • 7.6.3.3. India
    • 7.6.3.4. South Korea
    • 7.6.3.5. Indonesia
    • 7.6.3.6. Thailand
    • 7.6.3.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Oracle
• 9.2. Wolters Kluwer N.V.
• 9.3. Koninklijke Philips N.V.
• 9.4. GE HealthCare
• 9.5. Allscripts Healthcare LLC
• 9.6. Zynx Health, Inc.
• 9.7. eClinicalWorks
• 9.8. VisualDx
• 9.9. EBSCO Information Services
• 9.10. Elsevier